Nozyme Microcoated 40000 (Pancreatin Enteric-coated Microgranules)

Adult dose

Take 40,000 EP units of lipase activity per dose, 3 times daily with meals, with plenty of water, without chewing. Adjust the dose as appropriate according to the individual patient's needs, severity of disease, and food composition. Do not exceed a dose of 15,000~20,000 EP units of lipase activity per kg of body weight per day.

This medication should not be taken by individuals allergic to beef or pork. Additionally, those with a history of allergy to this medication or its components should avoid taking it. Patients with acute pancreatitis or those with chronic pancreatitis currently experiencing an acute episode should not use this medication. Patients with cystic fibrosis must consult a doctor or pharmacist before taking this medication. Women who are pregnant or may become pregnant should take this medication under the guidance of a doctor due to uncertainties regarding fetal safety. Nursing women must exercise caution as it is unknown whether this medication passes into breast milk, and they should consult a healthcare professional. Individuals taking folic acid supplements should be aware that this medication may interfere with folic acid absorption, and it is advisable to monitor folic acid levels through blood tests. Those taking antidiabetic medications such as acarbose or miglitol should manage their blood sugar carefully, as this medication may reduce the effectiveness of these antidiabetics. Caution is also needed for patients with gout, renal failure, or hyperuricemia, as this medication may increase blood uric acid levels. If symptoms of an allergic reaction such as skin rash, sneezing, or difficulty breathing occur while taking this medication, it should be discontinued immediately, and a doctor should be consulted. Symptoms such as decreased appetite, dizziness, rhinitis, diarrhea, abdominal pain, nausea, vomiting, oral inflammation, skin rash, and fatigue may occur, and if abnormal symptoms appear, it is necessary to stop taking the medication and consult a professional. Particularly, patients with cystic fibrosis should be monitored carefully for serious gastrointestinal issues such as bowel obstruction or colitis. Care should also be taken when administering this medication to children, as they may develop ulcers around the mouth. Taking excessive amounts may elevate uric acid levels, so the dosage should be respected. This medication is used to improve indigestion due to pancreatic disease, and care should be taken to avoid inhalation of the powder form. If symptoms do not improve after taking for more than two weeks, discontinue use and consult a doctor or pharmacist. Dosage adjustments must be made under the guidance of a doctor and tailored appropriately according to symptoms. When taking this medication, it should be swallowed whole without chewing, with sufficient water, and special attention should be given to ensure that children do not retain the medication in their mouths for a long time. This medication should be stored out of the reach of children, away from direct sunlight, and in a cool, dry place to maintain quality and avoid misuse. It is advised not to transfer it to other containers.

• Erythema
• sneezing
• urticaria
• skin rash
• bronchospasm
• loss of appetite
• dizziness
• balance disorder
• rhinitis
• diarrhea

This medication must be stored in a tightly sealed container to protect it from exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the medication's effectiveness and safety.

Appearance

White enteric-coated microgranules in an aluminum foil pouch

Package unit

100 packets/box, 10 packets/box, 30 packets/box